
The High Court of J&K and Ladakh has directed Kashmir Medical Supplies Corporation Limited (JKMSCL) to furnish details of supplies made to Government Medical College (GMC), Srinagar during the financial year 2025–26.
A Division Bench of Chief Justice Arun Palli and Justice Rajnesh Oswal ordered the Corporation to file an affidavit attesting to the details by April 29. The Bench was hearing a Public Interest Litigation (PIL) seeking court’s intervention to direct the authorities to immediately ensure uninterrupted availability and supply of anti-haemophilic drugs and essential clotting factor concentrates to Government Medical College, Srinagar and all other designated treatment centers across the Jammu & Kashmir
The PIL highlights the complete non-availability of the essential life-saving drugs like Factor VIII, Factor IX and Von Willebrand factor drugs, underlining that the patients in Jammu and Kashmir have to undergo a great deal of tribulations to get these drugs.
Moreover, the PIL seeks to release without any further delay, the entire quantity of anti-haemophilic drugs lying stocked with Jammu and Kashmir Medical Supplies Corporation Ltd to the concerned hospitals as per annual and supplementary requisitions raised by the concerned agencies.
In October last year, the High Court had observed the matter as “sensitive” and had asked the Managing Director, JKMSCL to submit a detailed report regarding the non-availability of anti-haemophilic drugs in hospitals in Jammu and Kashmir.
Advocate Iman Abdul Muizz on behalf of the Haemophilia Society of Kashmir that has filed the PIL last year, submitted that compliance report had been filed and he would file additional affidavit in response thereto. He prayed for a short accommodation to carry out the same.
Meanwhile, the Court directed the JKMSCL to file an affidavit indicating the supplies provided by the Corporation to the GMC Srinagar during the financial year 2025- 2026.






